pharma · high blood pressure · increased blood clotting
APREMEDA s.r.o
s.r.o.
APREMEDA s.r.o patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
EU HQ
2020 Founded
18 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Founded
- 2020
- Employees
- 18
- Programs
- 5
- Drugs
- 16
- Patents
- 0
APREMEDA s.r.o patents
0 pharmaceutical patents indexed for APREMEDA s.r.o. 0 expire within 24 months.
APREMEDA s.r.o has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does APREMEDA s.r.o have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do APREMEDA s.r.o patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.